TerminatedPhase 2NCT00847379
Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
Studying Becker muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- PTC Therapeutics
- Principal Investigator
- Leone Atkinson, M.D., Ph.D.PTC Therapeutics
- Intervention
- Ataluren(drug)
- Enrollment
- 173 enrolled
- Eligibility
- 5 years · MALE
- Timeline
- 2009 – 2010
Study locations (30)
- University of California - Davis, Sacramento, California, United States
- Department of Rehabilitation, The Children's Hospital, Aurora, Colorado, United States
- Child Neurology Center of NW Florida, Gulf Breeze, Florida, United States
- University of Iowa Children's Hospital, Division of Child Neurology, Iowa City, Iowa, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Children's Hospital of Boston, Boston, Massachusetts, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Washington University Medical School, St Louis, Missouri, United States
- Columbia University, New York, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Shriners Hospital for Children-Portland, Portland, Oregon, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Southwestern University, Dallas, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Genzyme, a Sanofi Company
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00847379 on ClinicalTrials.govOther trials for Becker muscular dystrophy
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07565272Usability and User Experience of a Virtual Reality Rehabilitation Game Platform in Individuals With Duchenne Muscular DystrophyIstanbul University
- ENROLLING BY INVITATIONNANCT07543302Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?taVNS AB
- RECRUITINGNCT07515235DMD Gene Variants and Cardiac Dysfunction in Young Males With DystrophinopathiesAristotle University Of Thessaloniki
- RECRUITINGNANCT07415421Parathyroidectomy After Kidney TransplantationAarhus University Hospital
- ACTIVE NOT RECRUITINGNCT07519720An Assessment of Risk Factors for Osteosarcopenia in Older Adults - the Role of Prevention, Lifestyle, Physical Activity and Education.Wroclaw University of Health and Sport Sciences
- ENROLLING BY INVITATIONPHASE1NCT07178327Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101Shanghai TTM-Bio Technology Co., Ltd
- RECRUITINGNCT07565051Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?University Hospital, Geneva
- RECRUITINGNANCT06949280Metabolic Health, Bones and Nuts During Weight Loss in AdultsRutgers, The State University of New Jersey